Breathing new life into clinical testing and diagnostics: perspectives on volatile biomarkers from breath

References

• Phillips M, Herrera J, Krishnan S, et al. Variation in volatile organic compounds in the breath of normal humans. J Chromatogr B Biomed Sci Appl. 1999;729(1–2):75–88.
   PubMedGoogle Scholar
• Fabian P, Brain J, Houseman EA, et al. Origin of exhaled breath particles from healthy and human rhinovirus-infected subjects. J Aerosol Med Pulm Drug Deliv. 2011;24(3):137–147.
   PubMed Web of Science ®Google Scholar
• Bake B, Larsson P, Ljungkvist G, et al. Exhaled particles and small airways. Respir Res. 2019;20(1):8.
   PubMedGoogle Scholar
• Das S, Pal M. Review—Non-invasive monitoring of human health by exhaled breath analysis: a comprehensive review. J Electrochem Soc. 2020;167(3):037562.
   Web of Science ®Google Scholar
• Khoubnasabjafari M, Mogaddam MRA, Rahimpour E, et al. Breathomics: review of sample collection and analysis, data modeling and clinical applications. Crit Rev Anal Chem. 2021. DOI:https://doi.org/10.1080/10408347.2021.1889961
   Google Scholar
• Etzioni R, Urban N, Ramsey S, et al. The case for early detection. Nat Rev Cancer. 2003;3(4):243–252.
   PubMed Web of Science ®Google Scholar
• Organization WH. Early cancer diagnosis saves lives, cuts treatment costs 2017. [updated 3rd Feb 2017]. Available from: https://www.who.int/news/item/03-02-2017-early-cancer-diagnosis-saves-lives-cuts-treatment-costs
   Google Scholar
• Tsochatzis EA, Bosch J, Burroughs AK. Liver cirrhosis. Lancet. 2014;383(9930):1749–1761.
   PubMed Web of Science ®Google Scholar
• Holzhütter H-G, Wuensch T, Gajowski R, et al. A novel variant of the 13C-methacetin liver function breath test that eliminates the confounding effect of individual differences in systemic CO2 kinetics. Arch Toxicol. 2020;94(2):401–415.
   PubMed Web of Science ®Google Scholar
• Moon AM, Singal AG, Tapper EB. Contemporary epidemiology of chronic liver disease and cirrhosis. Clin Gastroenterol Hepatol. 2020;18(12):2650–2666.
   PubMed Web of Science ®Google Scholar
• Hossain N, Kanwar P, Mohanty SR. A comprehensive updated review of pharmaceutical and nonpharmaceutical treatment for NAFLD. Gastroenterol Res Pract. 2016;2016:7109270. 2016/02/23;2016:7109270.
   PubMed Web of Science ®Google Scholar
• van der Schee M, Pinheiro H, Gaude E. Breath biopsy for early detection and precision medicine in cancer. Ecancermedicalscience. 2018;12:ed84.
   PubMedGoogle Scholar
• Rezaie A, Buresi M, Lembo A, et al. Hydrogen and methane-based breath testing in gastrointestinal disorders: the North American consensus. Am J Gastroenterol. 2017;112(5):775–784.
   PubMed Web of Science ®Google Scholar
• Henson SJ, Majowicz SE, Masakure O, et al. Estimation of the costs of acute gastrointestinal illness in British Columbia, Canada. Int J Food Microbiol. 2008;/127(1–2):43–52.
   PubMed Web of Science ®Google Scholar
• Nirwan JS, Hasan SS, Babar Z-U-D, et al. Global prevalence and risk factors of gastro-oesophageal reflux disease (GORD): systematic review with meta-analysis. Sci Rep. 2020;10(1):5814.
   PubMed Web of Science ®Google Scholar
• IBS IA. Facts about IBS – Statistics 2021. [cited 2021 13th Sept 2021]. Available from: https://aboutibs.org/what-is-ibs/facts-about-ibs/statistics/
   Google Scholar
• Azim A, Barber C, Dennison P, et al. Exhaled volatile organic compounds in adult asthma: a systematic review. Eur Respir J. 2019;54(3):1900056.
   PubMed Web of Science ®Google Scholar
• Schleich FN, Zanella D, Stefanuto PH, et al. Exhaled volatile organic compounds are able to discriminate between neutrophilic and eosinophilic asthma. Am J Respir Crit Care Med. 2019;200(4):444–453.
   PubMed Web of Science ®Google Scholar
• Organization WH. The top 10 causes of death: World Health Organization; 2020. [updated 9th Dec 2020; cited 2021 13th Sept 2021]. Available from: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death
   Google Scholar
• Pauling L, Robinson AB, Teranishi R, et al. Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography. Proc Natl Acad Sci U S A. 1971;68(10):2374–2376.
   PubMed Web of Science ®Google Scholar
• Tangerman A, Meuwese-Arends MT, Jansen JB. Cause and composition of foetor hepaticus. Lancet. 1994;343(8895):483.
   PubMed Web of Science ®Google Scholar
• Wang Z, Wang C. Is breath acetone a biomarker of diabetes? A historical review on breath acetone measurements. J Breath Res. 2013;7(3):037109.
   PubMed Web of Science ®Google Scholar
• Unger J. Measuring the sweet smell of success in diabetes management. Ann Transl Med. 2014;2(12):119–119.
   PubMedGoogle Scholar
• Phillips M, Greenberg J, Awad J. Metabolic and environmental origins of volatile organic compounds in breath. J Clin Pathol. 1994;47(11):1052–1053.
   PubMed Web of Science ®Google Scholar
• Blanchet L, Smolinska A, Baranska A, et al. Factors that influence the volatile organic compound content in human breath. J Breath Res. 2017;11(1):016013.
   PubMed Web of Science ®Google Scholar
• Leung NHL, Chu DKW, Shiu EYC, et al. Respiratory virus shedding in exhaled breath and efficacy of face masks. Nat Med. 2020;26(5):676–680.
   PubMed Web of Science ®Google Scholar
• Li X, Li J, Ge Q, et al. Detecting SARS-CoV-2 in the breath of COVID-19 patients [Original research]. Front Med (Lausanne). 2021;8(210):604392.
   PubMedGoogle Scholar
• Smolinska A, Jessop DS, Pappan KL, et al. The SARS-CoV-2 viral load in COVID-19 patients is lower on face mask filters than on nasopharyngeal swabs. Sci Rep. 2021;11(1):13476.
   PubMed Web of Science ®Google Scholar
• Holden KA, Ibrahim W, Salman D, et al. Use of the ReCIVA device in breath sampling of patients with acute breathlessness: a feasibility study. ERJ Open Res. 2020;6(4): 00119-2020.
   PubMedGoogle Scholar
• Wilson AD. Noninvasive early disease diagnosis by electronic-nose and related VOC-detection devices. Biosensors. 2020;10(7):73.
   Google Scholar
• Brinkman P, van de Pol MA, Gerritsen MG, et al. Exhaled breath profiles in the monitoring of loss of control and clinical recovery in asthma. Clin Exp Allergy. 2017;47(9):1159–1169.
   PubMed Web of Science ®Google Scholar
• Saidi T, Zaim O, Moufid M, et al. Exhaled breath analysis using electronic nose and gas chromatography–mass spectrometry for non-invasive diagnosis of chronic kidney disease, diabetes mellitus and healthy subjects. Sens Actuators, B. 2018;257:178–188.
   Web of Science ®Google Scholar
• Španěl P, Smith D. Progress in SIFT-MS: breath analysis and other applications. Mass Spectrom Rev. 2011;30(2):236–267.
   PubMed Web of Science ®Google Scholar
• Mayhew CAB, Herbig J, Beauchamp J. Proton transfer reaction mass spectrometry. In Beauchamp JD, Pleil J, editors. Breathborne biomarkers and the human volatilome. 2nd ed. New York, NY: Elsevier; 2020.
   Google Scholar
• Mohajeri MH, Brummer RJM, Rastall RA, et al. The role of the microbiome for human health: from basic science to clinical applications. Eur J Nutr. 2018;57(Suppl 1):1–14.
   PubMedGoogle Scholar
• Dukowicz AC, Lacy BE, Levine GM. Small intestinal bacterial overgrowth: a comprehensive review. Gastroenterol Hepatol (N Y). 2007;3(2):112–122.
   PubMedGoogle Scholar
• Shah ED. Breath test or duodenal aspirate for small intestinal bacterial overgrowth: still no breath of fresh air. Dig Dis Sci. 2021;66(6):1770–1771.
   PubMed Web of Science ®Google Scholar
• Erdogan A, Rao SS, Gulley D, et al. Small intestinal bacterial overgrowth: duodenal aspiration vs glucose breath test. Neurogastroenterol Motil. 2015;r27(4):481–489.
   PubMed Web of Science ®Google Scholar
• Lee SM, Falconer IHE, Madden T, et al. Characteristics of oxygen concentration and the role of correction factor in real-time GI breath test. BMJ Open Gastroenterol. 2021;8(1):e000640.
   PubMed Web of Science ®Google Scholar
• Pimentel M, Saad RJ, Long MD, et al. ACG clinical guideline: small intestinal bacterial overgrowth. Off J Am Coll Gastroenterol | ACG. 2020;115(2):165–178.
   Google Scholar
• Storhaug CL, Fosse SK, Fadnes LT. Country, regional, and global estimates for lactose malabsorption in adults: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2017;2(10):738–746.
   PubMed Web of Science ®Google Scholar
• Misselwitz B, Butter M, Verbeke K, et al. Update on lactose malabsorption and intolerance: pathogenesis, diagnosis and clinical management. Gut. 2019;68(11):2080–2091.
   PubMed Web of Science ®Google Scholar
• Perets TT, Hamouda D, Layfer O, et al. Small intestinal bacterial overgrowth may increase the likelihood of lactose and sorbitol but not fructose intolerance false positive diagnosis. Ann Clin Lab Sci. 2017;47(4):447–451.
   PubMed Web of Science ®Google Scholar
• Chatterjee S, Park S, Low K, et al. The degree of breath methane production in IBS correlates with the severity of constipation. Am J Gastroenterol. 2007;102(4):837–841.
   PubMed Web of Science ®Google Scholar
• Losurdo G, Leandro G, Ierardi E, et al. Breath tests for the non-invasive diagnosis of small intestinal bacterial overgrowth: a systematic review with meta-analysis. J Neurogastroenterol Motil. 2020;26(1):16–28.
   PubMed Web of Science ®Google Scholar
• Jirapinyo P, Makuvire TT, Dong WY, et al. Impact of oral-cecal transit time on the interpretation of lactulose breath tests after RYGB: a personalized approach to the diagnosis of SIBO. Obes Surg. 2019;29(3):771–775.
   PubMed Web of Science ®Google Scholar
• Kurada S, Alkhouri N, Fiocchi C, et al. Review article: breath analysis in inflammatory bowel diseases. Aliment Pharmacol Ther. 2015;41(4):329–341.
   PubMed Web of Science ®Google Scholar
• Oka P, Parr H, Barberio B, et al. Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;/5(10):908–917.
   PubMed Web of Science ®Google Scholar
• Mearin F, Lacy BE, Chang L, et al. Bowel disorders. Gastroenterology. 2016;150(6):P1393–1407.E5.
   Web of Science ®Google Scholar
• Camilleri M. Review article: biomarkers and personalised therapy in functional lower gastrointestinal disorders. Aliment Pharmacol Ther. 2015;42(7):818–828.
   PubMed Web of Science ®Google Scholar
• Baranska A, Mujagic Z, Smolinska A, et al. Volatile organic compounds in breath as markers for irritable bowel syndrome: a metabolomic approach. Aliment Pharmacol Ther. 2016;44(1):45–56.
   PubMed Web of Science ®Google Scholar
• Cauchi M, Fowler DP, Walton C, et al. Application of gas chromatography mass spectrometry (GC–MS) in conjunction with multivariate classification for the diagnosis of gastrointestinal diseases. Metabolomics. 2014;10(6):1113–1120.
   Web of Science ®Google Scholar
• Ahmed I, Greenwood R, Costello Bde L, et al. An investigation of fecal volatile organic metabolites in irritable bowel syndrome. PLoS One. 2013;8(3):e58204.
   PubMed Web of Science ®Google Scholar
• Arasaradnam RP, Westenbrink E, McFarlane MJ, et al. Differentiating coeliac disease from irritable bowel syndrome by urinary volatile organic compound analysis-a pilot study. PLoS One. 2014;9(10):e107312.
   PubMed Web of Science ®Google Scholar
• Smolinska A, Tedjo DI, Blanchet L, et al. Volatile metabolites in breath strongly correlate with gut microbiome in CD patients. Anal Chim Acta. 2018;1025:1–11.
   PubMed Web of Science ®Google Scholar
• Hwang C, Ross V, Mahadevan U. Micronutrient deficiencies in inflammatory bowel disease: from a to zinc. Inflamm Bowel Dis. 2012;18(10):1961–1981.
   PubMed Web of Science ®Google Scholar
• Wan Q, Zhao R, Xia L, et al. Inflammatory bowel disease and risk of gastric, small bowel and colorectal cancer: a meta-analysis of 26 observational studies. J Cancer Res Clin Oncol. 2021;147(4):1077–1087.
   PubMed Web of Science ®Google Scholar
• Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340(6):448–454.
   PubMed Web of Science ®Google Scholar
• Van Malderen K, De Winter BY, De Man JG, et al. Volatomics in inflammatory bowel disease and irritable bowel syndrome. EBioMedicine. 2020;54:102725.
   PubMed Web of Science ®Google Scholar
• Ajibola OA, Smith D, Spaněl P, et al. Effects of dietary nutrients on volatile breath metabolites. J Nutr Sci. 2013;2:e34.
   PubMedGoogle Scholar
• Belizario JE, Faintuch J, Malpartida MG. Breath biopsy and discovery of exclusive volatile organic compounds for diagnosis of infectious diseases. Front Cell Infect Microbiol. 2020;10(564194):564194.
   PubMedGoogle Scholar
• Raninen KJ, Lappi JE, Mukkala ML, et al. Fiber content of diet affects exhaled breath volatiles in fasting and postprandial state in a pilot crossover study. Nutr Res. 2016;36(6):612–619.
   PubMed Web of Science ®Google Scholar
• Hartiala J, Bennett BJ, Tang WH, et al. Comparative genome-wide association studies in mice and humans for trimethylamine N-oxide, a proatherogenic metabolite of choline and L-carnitine. Arterioscler Thromb Vasc Biol. CARDIoGRAM Consortium. 2014;34(6):1307–1313.
   PubMed Web of Science ®Google Scholar
• Ruzsanyi V, Peter Kalapos M, Schmidl C, et al. Breath profiles of children on ketogenic therapy. J Breath Res. 2018;12(3):036021.
   PubMed Web of Science ®Google Scholar
• De Preter V, Joossens M, Ballet V, et al. Metabolic profiling of the impact of oligofructose-enriched inulin in Crohn's disease patients: a double-blinded randomized controlled trial. Clin Transl Gastroenterol. 2013;4(1):e30.
   PubMedGoogle Scholar
• De Preter V, Hamer HM, Windey K, et al. The impact of pre- and/or probiotics on human colonic metabolism: does it affect human health? Mol Nutr Food Res. 2011;55(1):46–57.
   PubMed Web of Science ®Google Scholar
• Xiang L, Wu S, Hua Q, et al. Volatile organic compounds in human exhaled breath to diagnose gastrointestinal cancer: a meta-analysis. Front Oncol. 2021;11: 606915–606915.
   PubMed Web of Science ®Google Scholar
• GBD-Cirrhosis-Collaborators. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet Gastroenterol Hepatol. 2020;5(3):245–266.
   PubMed Web of Science ®Google Scholar
• Ratib S, Fleming KM, Crooks CJ, et al. 1 And 5 year survival estimates for people with cirrhosis of the liver in England, 1998–2009: a large population study. J Hepatol. 2014;60(2):282–289.
   PubMed Web of Science ®Google Scholar
• Sharma A, Nagalli S. Chronic liver disease. Treasure Island, FL: StatPearls; 2021.
   Google Scholar
• Papastergiou V, Tsochatzis E, Burroughs AK. Non-invasive assessment of liver fibrosis. Ann Gastroenterol. 2012;25(3):218–231.
   PubMedGoogle Scholar
• Neuberger J, Patel J, Caldwell H, et al. Guidelines on the use of liver biopsy in clinical practice from the British Society of Gastroenterology, the Royal College of Radiologists and the Royal College of Pathology. Gut. 2020;69(8):1382–1403.
   PubMed Web of Science ®Google Scholar
• Harman DJ, Ryder SD, James MW, et al. Direct targeting of risk factors significantly increases the detection of liver cirrhosis in primary care: a cross-sectional diagnostic study utilising transient elastography. BMJ Open. 2015;5(4):e007516.
   PubMed Web of Science ®Google Scholar
• Khan V, Putluri N, Sreekumar A, et al. Current applications of metabolomics in cirrhosis. Metabolites. 2018;8(4):67.
   Web of Science ®Google Scholar
• Hoang SA, Oseini A, Feaver RE, et al. Gene expression predicts histological severity and reveals distinct molecular profiles of nonalcoholic fatty liver disease. Sci Rep. 2019;9(1):12541.
   PubMedGoogle Scholar
• Gerhard GS, Legendre C, Still CD, et al. Transcriptomic profiling of obesity-related nonalcoholic steatohepatitis reveals a core set of fibrosis-specific genes. J Endocr Soc. 2018;2(7):710–726.
   PubMed Web of Science ®Google Scholar
• Govaere O, Cockell S, Tiniakos D, et al. Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis. Sci Transl Med. 2020;12(572):eaba4448.
   PubMed Web of Science ®Google Scholar
• Suppli MP, Rigbolt KTG, Veidal SS, et al. Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals. Am J Physiol Gastrointest Liver Physiol. 2019;316(4):G462–G472.
   PubMed Web of Science ®Google Scholar
• Miele L, Grieco A, Armuzzi A, et al. Hepatic mitochondrial beta-oxidation in patients with nonalcoholic steatohepatitis assessed by 13C-octanoate breath test. Am J Gastroenterol. 2003;98(10):2335–2336.
   PubMed Web of Science ®Google Scholar
• Braden B, Faust D, Sarrazin U, et al. 13C-methacetin breath test as liver function test in patients with chronic hepatitis C virus infection. Aliment Pharmacol Ther. 2005;21(2):179–185.
   PubMed Web of Science ®Google Scholar
• Park GJ, Katelaris PH, Jones DB, et al. The C-caffeine breath test distinguishes significant fibrosis in chronic hepatitis B and reflects response to lamivudine therapy. Aliment Pharmacol Ther. 2005;22(5):395–403.
   PubMed Web of Science ®Google Scholar
• Li H, Toth E, Cherrington NJ. Alcohol metabolism in the progression of human nonalcoholic steatohepatitis. Toxicol Sci. 2018;164(2):428–438.
   PubMed Web of Science ®Google Scholar
• Dietrich CG, Gotze O, Geier A. Molecular changes in hepatic metabolism and transport in cirrhosis and their functional importance. World J Gastroenterol. 2016;22(1):72–88.
   PubMed Web of Science ®Google Scholar
• Elbekai RH, Korashy HM, El-Kadi AO. The effect of liver cirrhosis on the regulation and expression of drug metabolizing enzymes. Curr Drug Metab. 2004;5(2):157–167.
   PubMed Web of Science ®Google Scholar
• Hernandez-Gea V, Toffanin S, Friedman SL, et al. Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma. Gastroenterology. 2013;144(3):512–527.
   PubMed Web of Science ®Google Scholar
• Straub AC, Clark KA, Ross MA, et al. Arsenic-stimulated liver sinusoidal capillarization in mice requires NADPH oxidase-generated superoxide. J Clin Invest. 2008;118(12):3980–3989.
   PubMed Web of Science ®Google Scholar
• Gaude E, Nakhleh MK, Patassini S, et al. Targeted breath analysis: exogenous volatile organic compounds (EVOC) as metabolic pathway-specific probes. J Breath Res. 2019;13(3):032001.
   PubMed Web of Science ®Google Scholar
• Dweik RA, Amann A. Exhaled breath analysis: the new frontier in medical testing. J Breath Res. 2008;2(3):030301.
   Web of Science ®Google Scholar
• Kaji H, Hisamura M, Saito N, et al. Evaluation of volatile sulfur compounds in the expired alveolar gas in patients with liver cirrhosis. Clin Chim Acta. 1978;85(3):279–284.
   PubMed Web of Science ®Google Scholar
• Dadamio J, Van den Velde S, Laleman W, et al. Breath biomarkers of liver cirrhosis. J Chromatogr B Analyt Technol Biomed Life Sci. 2012;905:17–22.
   PubMed Web of Science ®Google Scholar
• Pijls KE, Smolinska A, Jonkers DM, et al. A profile of volatile organic compounds in exhaled air as a potential non-invasive biomarker for liver cirrhosis. Sci Rep. 2016;6:19903.
   PubMed Web of Science ®Google Scholar
• Friedman MI, Preti G, Deems RO, et al. Limonene in expired lung air of patients with liver disease. Dig Dis Sci. 1994;39(8):1672–1676.
   PubMed Web of Science ®Google Scholar
• Ferrandino G, Orf I, Smith R, et al. Breath biopsy assessment of liver disease using an exogenous volatile organic compound-toward improved detection of liver impairment. Clin Transl Gastroenterol. 2020;11(9):e00239.
   PubMed Web of Science ®Google Scholar
• Fernandez Del Rio R, O'Hara ME, Holt A, et al. Volatile biomarkers in breath associated with liver cirrhosis – comparisons of pre- and post-liver transplant breath samples. EBioMedicine. 2015;2(9):1243–1250.
   PubMed Web of Science ®Google Scholar
• Sinha R, Lockman KA, Homer NZM, et al. Volatomic analysis identifies compounds that can stratify non-alcoholic fatty liver disease. JHEP Rep. 2020;2(5):100137.
   Google Scholar
• Thomas JN, Roopkumar J, Patel T. Machine learning analysis of volatolomic profiles in breath can identify non-invasive biomarkers of liver disease: a pilot study. PLoS One. 2021;16(11):e0260098.
   PubMed Web of Science ®Google Scholar
• Miyazawa M, Shindo M, Shimada T. Metabolism of (+)- and (-)-limonenes to respective carveols and perillyl alcohols by CYP2C9 and CYP2C19 in human liver microsomes. Drug Metab Dispos. 2002;30(5):602–607.
   PubMed Web of Science ®Google Scholar
• Murgia A, Ahmed Y, Sweeney K, et al. Breath-taking perspectives and preliminary data toward early detection of chronic liver diseases. Biomedicines. 2021;9(11):1563.
   PubMedGoogle Scholar
• Morisco F, Aprea E, Lembo V, et al. Rapid "breath-print" of liver cirrhosis by proton transfer reaction time-of-flight mass spectrometry. A pilot study. PLoS One. 2013;8(4):e59658.
   PubMed Web of Science ®Google Scholar
• Van den Velde S, Nevens F, Van Hee P, et al. GC-MS analysis of breath odor compounds in liver patients. J Chromatogr B Analyt Technol Biomed Life Sci. 2008;875(2):344–348.
   PubMed Web of Science ®Google Scholar
• Gorowska-Kowolik K, Chobot A, Kwiecien J. 13C Methacetin Breath Test for assessment of microsomal liver function: methodology and clinical application . Gastroenterol Res Pract. 2017;2017:7397840.
   PubMed Web of Science ®Google Scholar
• Stockmann M, Lock JF, Malinowski M, et al. The LiMAx test: a new liver function test for predicting postoperative outcome in liver surgery. HPB. 2010;12(2):139–146.
   PubMed Web of Science ®Google Scholar
• Stavropoulos G, van Munster K, Ferrandino G, et al. Liver impairment-the potential application of volatile organic compounds in hepatology. Metabolites. 2021;11(9):618.
   PubMed Web of Science ®Google Scholar
• Rufo JC, Madureira J, Fernandes EO, et al. Volatile organic compounds in asthma diagnosis: a systematic review and meta-analysis. Allergy. 2016;71(2):175–188.
   PubMed Web of Science ®Google Scholar
• Finamore P, Scarlata S, Incalzi RA. Breath analysis in respiratory diseases: state-of-the-art and future perspectives. Expert Rev Mol Diagn. 2019;19(1):47–61.
   PubMed Web of Science ®Google Scholar
• Ratiu IA, Ligor T, Bocos-Bintintan V, et al. Volatile organic compounds in exhaled breath as fingerprints of lung cancer, asthma and COPD. J Clin Med. 2020;10(1):32.
   PubMed Web of Science ®Google Scholar
• Yamada YI, Yamada G, Otsuka M, et al. Volatile organic compounds in exhaled breath of idiopathic pulmonary fibrosis for discrimination from healthy subjects. Lung. 2017;195(2):247–254.
   PubMed Web of Science ®Google Scholar
• Weber R, Haas N, Baghdasaryan A, et al. Volatile organic compound breath signatures of children with cystic fibrosis by real-time SESI-HRMS. ERJ Open Res. 2020;6(1): 00171-2019.
   PubMedGoogle Scholar
• Neerincx AH, Geurts BP, van Loon J, et al. Detection of Staphylococcus aureus in cystic fibrosis patients using breath VOC profiles. J Breath Res. 2016;10(4):046014.
   PubMed Web of Science ®Google Scholar
• Töreyin ZN, Ghosh M, Göksel Ö, et al. Exhaled breath analysis in diagnosis of malignant pleural mesothelioma: systematic review. Int J Environ Res Public Health. 2020;17(3):1110.
   PubMed Web of Science ®Google Scholar
• Brinkman P, Zee AM, Wagener AH. Breathomics and treatable traits for chronic airway diseases. Curr Opin Pulm Med. 2019;25(1):94–100.
   PubMed Web of Science ®Google Scholar
• Schleich F, Brusselle G, Louis R, et al. Heterogeneity of phenotypes in severe asthmatics. The Belgian Severe Asthma Registry (BSAR). Respir Med. 2014;08(12):1723–1732.
   Google Scholar
• Barnes PJ. Inflammatory endotypes in COPD. Allergy. 2019;74(7):1249–1256.
   PubMed Web of Science ®Google Scholar
• Brightling C, Greening N. Airway inflammation in COPD: progress to precision medicine. Eur Respir J. 2019;54(2):1900651.
   PubMed Web of Science ®Google Scholar
• Segal LN, Martinez FJ. Chronic obstructive pulmonary disease subpopulations and phenotyping. J Allergy Clin Immunol. 2018;141(6):1961–1971.
   PubMed Web of Science ®Google Scholar
• Schleich FN, Manise M, Sele J, et al. Distribution of sputum cellular phenotype in a large asthma cohort: predicting factors for eosinophilic vs neutrophilic inflammation. BMC Pulm Med. 2013;13:11.
   PubMed Web of Science ®Google Scholar
• Smolinska A, Klaassen EMM, Dallinga JW, et al. Profiling of volatile organic compounds in exhaled breath as a strategy to find early predictive signatures of asthma in children. PLoS One. 2014;9(4):e95668.
   PubMed Web of Science ®Google Scholar
• Neerincx AH, Vijverberg SJH, Bos LDJ, et al. Breathomics from exhaled volatile organic compounds in pediatric asthma. Pediatr Pulmonol. 2017;52(12):1616–1627.
   PubMed Web of Science ®Google Scholar
• van Vliet D, Smolinska A, Jöbsis Q, et al. Can exhaled volatile organic compounds predict asthma exacerbations in children? J Breath Res. 2017;11(1):016016.
   PubMed Web of Science ®Google Scholar
• Robroeks CM, van Berkel JJ, Jöbsis Q, et al. Exhaled volatile organic compounds predict exacerbations of childhood asthma in a 1-year prospective study. Eur Respir J. 2013;42(1):98–106.
   PubMed Web of Science ®Google Scholar
• Dryahina K, Sovová K, Nemec A, et al. Differentiation of pulmonary bacterial pathogens in cystic fibrosis by volatile metabolites emitted by their in vitro cultures: Pseudomonas aeruginosa, Staphylococcus aureus, Stenotrophomonas maltophilia and the Burkholderia cepacia complex. J Breath Res. 2016;10(3):037102.
   PubMed Web of Science ®Google Scholar
• Kos R, Brinkman P, Neerincx AH, et al. Targeted exhaled breath analysis for detection of Pseudomonas aeruginosa in cystic fibrosis patients. J Cyst Fibros. 2021;21:e28–e34.
   Web of Science ®Google Scholar
• Giovannini G, Haick H, Garoli D. Detecting COVID-19 from breath: a game changer for a big challenge. ACS Sens. 2021;6(4):1408–1417.
   PubMed Web of Science ®Google Scholar
• Krilaviciute A, Heiss JA, Leja M, et al. Detection of cancer through exhaled breath: a systematic review. Oncotarget. 2015;6(36):38643–38657.
   PubMedGoogle Scholar
• Queralto N, Berliner AN, Goldsmith B, et al. Detecting cancer by breath volatile organic compound analysis: a review of array-based sensors. J Breath Res. 2014;8(2):027112.
   PubMed Web of Science ®Google Scholar
• Sun X, Shao K, Wang T. Detection of volatile organic compounds (VOCs) from exhaled breath as noninvasive methods for cancer diagnosis. Anal Bioanal Chem. 2016;408(11):2759–2780.
   PubMed Web of Science ®Google Scholar
• Jia Z, Patra A, Kutty VK, et al. Critical review of volatile organic compound analysis in breath and in vitro cell culture for detection of lung cancer. Metabolites. 2019;9(3):52.
   Web of Science ®Google Scholar
• Di Lena M, Porcelli F, Altomare DF. Volatile organic compounds as new biomarkers for colorectal cancer: a review. Colorectal Dis. 2016;18(7):654–663.
   PubMed Web of Science ®Google Scholar
• Hanna GB, Boshier PR, Markar SR, et al. Accuracy and methodologic challenges of volatile organic compound-based exhaled breath tests for cancer diagnosis: a systematic review and meta-analysis. JAMA Oncol. 2019;5(1):e182815.
   PubMed Web of Science ®Google Scholar
• Sahota AS, Gowda R, Arasaradnam RP, et al. A simple breath test for tuberculosis using ion mobility: a pilot study. Tuberculosis . 2016;99:143–146.
   PubMed Web of Science ®Google Scholar
• Phillips M, Basa-Dalay V, Blais J, et al. Point-of-care breath test for biomarkers of active pulmonary tuberculosis. Tuberculosis. 2012;92(4):314–320.
   PubMed Web of Science ®Google Scholar
• Koo S, Thomas HR, Daniels SD, et al. A breath fungal secondary metabolite signature to diagnose invasive Aspergillosis. Clin Infect Dis. 2014;59(12):1733–1740.
   PubMed Web of Science ®Google Scholar
• Chambers ST, Bhandari S, Scott-Thomas A, et al. Novel diagnostics: progress toward a breath test for invasive Aspergillus fumigatus. Med Mycol. 2011;49(Suppl 1):S54–S61.
   PubMed Web of Science ®Google Scholar
• Teny John LHK, Pappan O, Birch,  et al. Volatile compound analysis of breath from patients with Clostridium difficile infection for biomarker discovery and biological insight. Poster. Breath Biopsy Conference. Breath Biopsy Community; 2020. Available from: https://www.owlstonemedical.com/media/uploads/files/Final_-_CC1_poster.pdf
   Google Scholar
• Berna AZ, McCarthy JS, Wang RX, et al. Analysis of breath specimens for biomarkers of Plasmodium falciparum infection. J Infect Dis. 2015;212(7):1120–1128.
   PubMed Web of Science ®Google Scholar
• Berna AZ, McCarthy JS, Wang XR, et al. Diurnal variation in expired breath volatiles in malaria-infected and healthy volunteers. J Breath Res. 2018;12(4):046014.
   PubMed Web of Science ®Google Scholar
• Schaber CL, Katta N, Bollinger LB, et al. Breathprinting reveals malaria-associated biomarkers and mosquito attractants. J Infect Dis. 2018;217(10):1553–1560.
   PubMed Web of Science ®Google Scholar
• Brekelmans MP, Fens N, Brinkman P, et al. Smelling the diagnosis: the electronic nose as diagnostic tool in inflammatory arthritis. A case-reference study. PLoS One. 2016;11(3):e0151715.
   PubMed Web of Science ®Google Scholar
• Das S, Pal S, Mitra M. Significance of exhaled breath test in clinical diagnosis: a special focus on the detection of diabetes mellitus. J Med Biol Eng. 2016;36(5):605–624.
   PubMed Web of Science ®Google Scholar
• Tiele A, Wicaksono A, Daulton E, et al. Breath-based non-invasive diagnosis of Alzheimer's disease: a pilot study. J Breath Res. 2020;14(2):026003.
   PubMed Web of Science ®Google Scholar
• Tisch U, Schlesinger I, Ionescu R, et al. Detection of Alzheimer's and Parkinson's disease from exhaled breath using nanomaterial-based sensors. Nanomedicine. 2013;8(1):43–56.
   PubMed Web of Science ®Google Scholar
• Broza YY, Har-Shai L, Jeries R, et al. Exhaled breath markers for nonimaging and noninvasive measures for detection of multiple sclerosis. ACS Chem Neurosci. 2017;8(11):2402–2413.
   PubMed Web of Science ®Google Scholar
• Ratcliffe N, Wieczorek T, Drabińska N, et al. A mechanistic study and review of volatile products from peroxidation of unsaturated fatty acids: an aid to understanding the origins of volatile organic compounds from the human body. J Breath Res. 2020;14(3):034001.
   PubMed Web of Science ®Google Scholar
• McKay LF, Holbrook WP, Eastwood MA. Methane and hydrogen production by human intestinal anaerobic bacteria. Acta Pathol Microbiol Immunol Scand B. 1982;90(3):257–260.
   PubMedGoogle Scholar
• Beauchamp JD, Pleil JD. Simply breath-taking? Developing a strategy for consistent breath sampling. J Breath Res. 2013;7(4):042001.
   PubMed Web of Science ®Google Scholar
• Henderson B, Ruszkiewicz DM, Wilkinson M, et al. A benchmarking protocol for breath analysis: the peppermint experiment. J Breath Res. 2020;14(4):046008.
   PubMedGoogle Scholar
• Gibbs RA, Belmont JW, Hardenbol P, et al. The international HapMap project. Nature. 2003;426(6968):789–796.
   PubMed Web of Science ®Google Scholar
• Harshman SW, Pitsch RL, Davidson CN, et al. Evaluation of a standardized collection device for exhaled breath sampling onto thermal desorption tubes. J Breath Res. 2020;14(3):036004.
   PubMed Web of Science ®Google Scholar
• Farraia MV, Cavaleiro Rufo J, Paciência I, et al. The electronic nose technology in clinical diagnosis: a systematic review. Porto Biomed J. 2019;4(4):e42.
   PubMedGoogle Scholar
• Shrestha A, Prodhan UK, Mitchell SM, et al. Validity of a portable breath analyser (AIRE) for the assessment of lactose malabsorption. Nutrients. 2019;11(7):1636.
   Web of Science ®Google Scholar